About Javara Research
Javara Research is a Healthcare company based in Winston-salem (United States) founded in 2018. Clinical trials for pharmaceuticals are conducted across therapeutic areas. Javara Research has raised $44.98 million across 5 funding rounds from investors including General Atlantic. Its chief executive, as recorded, is Jennifer Byrne. Javara Research offers products and services including CRAACO Service and Infrastructure Provision. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its competitors include Vial, Alcanza Clinical Research and Global Coalition for Adaptive Research; 1 of its 3 listed competitors has raised funding.
Company details
Javara Research was founded in 2018 in Winston-Salem, United States, as a clinical research entity focused on the pharmaceutical sector. Trials are carried out in a broad spectrum of therapeutic areas, supported by an integrated platform designed for streamlined operations. Services encompass trial management and execution, with activities centered in the U.S. to facilitate industry partnerships and research advancements.
- Headquarters Winston-salem, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website javararesearch.com
- Social LinkedIn X Facebook Instagram
- Total Equity Funding$44.98M (USD)
in 5 rounds
- Latest Funding Round$6.6M (USD), Series B
May 2025
- Investors
Products & Services of Javara Research
Javara Research offers a comprehensive portfolio of products and services, including CRAACO Service and Infrastructure Provision.
Connects patients to trials at point of care for better access.
Offers training and infrastructure for conducting clinical trials efficiently.
Funding Insights of Javara Research
Javara Research has successfully raised a total of $44.98M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $6.6 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $44.98M
- Total Rounds 5
- Last Round Series B — $6.6M
- First Round $3.78M
(Aug 2019)
- Investors Count 1
All 5 funding rounds of Javara Research with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2025 | $6.6M | Series B | – | – | – |
| Nov 2023 | $9.43M | Debt – Conventional | – | – | – |
| Apr 2022 | $30M | Series B | – | General Atlantic | – |
| Aug 2020 | $4.6M | Series A | – | – | – |
| Aug 2019 | $3.78M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in Javara Research
Javara Research has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include General Atlantic.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity fund focused on global markets | 1980 | generalatlantic.com | New York, United States |
Investor details for Javara Research
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Javara Research
16 people are tracked at Javara Research (8 in leadership, 4 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Jennifer Byrne | CEO | Leadership |
Kathryn Robison | Executive Director, Human Resources | Leadership |
John Worden | VP, Strategic Development | Leadership |
Linda McCarty | Co-Founder, Chief Legal Officer & Privacy Officer | Leadership |
Chris Olson | Senior Director, Controller | Leadership |
Will Combs | Director Of Site Operations | Leadership |
Scott Chatterton | Vice President Of Business Development | Leadership |
Beau Garland | CSO (chief Of Site Operations) | Leadership |
Thomas H. Pike | Board Member | Board & advisors |
Jeff Kasher | Board Member | Board & advisors |
Josef H. Von Rickenbach | Board Member | Board & advisors |
Brett Zbar | Board Member | Board & advisors |
Heather Key Wilson | Senior Manager Accounting & Finance | Team |
Hope Griffin | Senior Human Resources Associate | Team |
Jami Smith | Manager, Project Strategy | Team |
Tevin Clemmons | Lead Operations Specialist | Team |
Complete people profiles for Javara Research
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Javara Research
3 dated milestones of Javara Research across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Javara Research is founded.
- Funding First funding round of $3.8M.
- Funding Latest funding round, Series B, of $6.6M.
Competitors of Javara Research
Javara Research has 3 listed competitors in our database, 1 of them funded. They include Vial, Alcanza Clinical Research and Global Coalition for Adaptive Research.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| vial.com | 2020 | San Francisco, United States | $67M | 65 | Healthcare data capture, clinical trials, and CRO services are provided. | |
| alcanzaclinical.com | 2021 | Methuen, United States | Clinical research site network focused on accelerating the development of new therapies by reducing barriers to participation | |||
| gcaresearch.org | 2017 | Lexington, United States | 21 | Nonprofit organization sponsors clinical trials for rare diseases worldwide. |
Detailed competitors of Javara Research
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Javara Research
The website of Javara Research (javararesearch.com) receives about 8.7K visits a month.
- Monthly visits8.7K
▼ 12.8% vs previous month
Websites whose visitors overlap most with Javara Research. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
mercurycr.us.com | mercurycr.us.com | 100% | #4,007,302 | – | |
cddgastro.com | cddgastro.com | 93% | #6,118,678 | – | |
| roseresearchcenter.com | 93% | 6.2K | #3,090,605 | View details | |
blandclinicpa.com | blandclinicpa.com | 92% | – | ||
oculusresearch.com | oculusresearch.com | 89% | #4,006,410 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for Javara Research
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Javara Research (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Javara Research
Complete news archive for Javara Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Javara Research
Javara Research was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Javara Research is headquartered in Winston-salem, United States. It is registered at Winston-salem, North Carolina, United States.
Jennifer Byrne is the CEO of Javara Research, as recorded in our data.
Javara Research is a funded company, having raised a total of $44.98M across 5 funding rounds to date. The company's 1st funding round was a Series A of $3.78M, raised on Aug 2019.
Javara Research was founded in 2018 in Winston-Salem, United States, as a clinical research entity focused on the pharmaceutical sector. Trials are carried out in a broad spectrum of therapeutic areas, supported by an integrated platform designed for streamlined operations. Services encompass trial management and execution, with activities centered in the U.S. to facilitate industry partnerships and research advancements.
Javara Research's top competitors include Vial, Alcanza Clinical Research and Global Coalition for Adaptive Research.
Javara Research offers CRAACO Service and Infrastructure Provision.
Javara Research has 1 investor. Key investors include General Atlantic.